This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Biden Versus Trump: Impact on ETF Investing World
by Sanghamitra Saha
Nov 3 election day is about three weeks away. An investing case should be worked out for the both the scenario ??? Biden or Trump win.
5 Sector ETFs Gaining in Double Digits to Start October
by Sweta Killa
Wall Street registered back-to-back weekly gains primarily on the back of prospects for another round of fiscal stimulus from Congress.
Top Sector ETFs From Wall Street's Best Week in 3 Months
by Sanghamitra Saha
Last week was cheery for Wall Street, with the S&P 500 and Nasdaq recording their best weekly advancement since July.
Investors Flock Green Energy Before Election: Top ETFs, Stocks
by Sweta Killa
Investors are rushing toward greener stocks ahead of 2020 elections. The former vice president Joe Biden, who proposed to build a green and clean infrastructure, is leading Donald Trump in the polls.
Best Performing ETFs of the Third Quarter
by Neena Mishra
We take a look at the best performing areas of Q3 and what lies ahead
Top-Performing ETF Areas of Last Week
by Sanghamitra Saha
Last week was moderate for Wall Street with the S&P 500, the Dow Jones and the Nasdaq gaining about 1.5%, 1.9% and 1.5%, respectively.
ETF Areas That Remained Strong in the First 9 Months of 2020
by Sweta Jaiswal, FRM
During the pandemic, investors continue to focus on opportunities for their portfolios cropping up from the new normal.
Winning ETF Areas After First Presidential Debate
by Sweta Jaiswal, FRM
Here we look at ETF areas that appear to be winning after the recently-concluded presidential debate.
Top-Performing ETFs of the Worst September Since 2011
by Sanghamitra Saha
After a superb August, September turned gloomy for Wall Street.
Beyond Clean Energy, 5 Best Global ETF Areas of Q3
by Sanghamitra Saha
The third quarter of 2020 has been all about coronavirus-related developments, global fiscal and monetary stimulus and coronavirus vaccine hopes.